Mostrando publicación

Pérez-García, S., Calamia, V., Hermida-Gómez, T., Gutiérrez-Cañas, I., Carrión, M., Villanueva-Romero, R., Castro, D., Martínez, C., Juarranz, Y., Blanco, F.J., Gomariz, R.P.

Proteomic analysis of synovial fibroblasts and articular chondrocytes co-cultures reveals valuable vip-modulated inflammatory and degradative proteins in osteoarthritis

(2021) International Journal of Molecular Sciences, 22 (12), art. no. 6441, .

DOI: 10.3390/ijms22126441


Osteoarthritis (OA) is the most common musculoskeletal disorder causing a great disability and a reduction in the quality of life. In OA, articular chondrocytes (AC) and synovial fibroblasts (SF) release innate‐derived immune mediators that initiate and perpetuate inflammation, inducing cartilage extracellular matrix (ECM) degradation. Given the lack of therapies for the treatment of OA, in this study, we explore biomarkers that enable the development of new therapeutical approaches. We analyze the set of se‐ creted proteins in AC and SF co‐cultures by stable isotope labeling with amino acids (SILAC). We describe, for the first time, 115 proteins detected in SF‐AC co‐cultures stimulated by fibronectin fragments (Fn‐fs). We also study the role of the vasoactive intestinal peptide (VIP) in this secretome, providing new proteins involved in the main events of OA, confirmed by ELISA and multiplex analyses. VIP decreases proteins involved in the inflammatory process (CHI3L1, PTX3), complement activation (C1r, C3), and carti‐ lage ECM degradation (DCN, CTSB and MMP2), key events in the initiation and progression of OA. Our results support the anti‐ inflammatory and anti‐catabolic properties of VIP in rheumatic diseases and provide potential new targets for OA treatment.